跳至主要内容
临床试验/NCT02020954
NCT02020954Unknown不适用

Prospective Cohort Study of Patients With Mutations in the Dystrophin Gene (X Linked Dilated Cardiomyopathy and Becker Muscular Dystrophy)

Karim WAHBI1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Left ventricular ejection fraction

研究概览

简要总结

The purpose of this study is to determine whether electrocardiogram, echocardiography, cardiac MRI, sera biomarkers can improve early detection of myocardial involvement and clinical outcome.

详细描述

A cohort of 100 patients with mutations in the dystrophin gene associated with Becker muscular dystrophy and/or dilated cardiomyopathy will be included (patients with Duchenne muscular dystrophy are excluded).

Patients with undergo at baseline the following workups: electrocardiogram, echocardiography, cardiac MRI, sera biomarkers measurement.

At 3 years and 5 years, patients will be investigated according to the same protocol and occurrence of cardiac adverse events in the meanwhile will be recorded.

Statistical analysis will assess correlations between cardiac phenotype and DMD mutations and prognostic value of cardiac investigations.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • mutation in the DMD gene
  • Becker muscular dystrophy and/or dilated cardiomyopathy
  • age>18 years
  • affiliation to the French medical insurance

排除标准

  • Duchenne muscular dystrophy
  • Any other chronic disease that may be associated with heart disease

结局指标

主要结局

Left ventricular ejection fraction

时间窗: 3 years

次要结局

  • Composite endpoint: hospitalisation for heart failure, death due to heart failure(3 years)

研究者

发起方
Karim WAHBI
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Karim WAHBI

MD, PhD

Institut de Myologie, France

研究点 (1)

Loading locations...

相似试验

Prospective Becker-Heart-Study | 临床试验